HR
CELG

Howe & Rusling’s Celgene Corp CELG Stock Holding History

Howe & Rusling’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-325
Closed -$32K – 909
2019
Q3 		$32K Buy
325
+75
+30% +$7.13K 0.01% 338
2019
Q2 		$23K Sell
250
-6
-2% -$570 ﹤0.01% 357
2019
Q1 		$24K Sell
256
-11,038
-98% -$965K ﹤0.01% 359
2018
Q4 		$724K Sell
11,294
-4,350
-28% -$321K 0.15% 96
2018
Q3 		$1.4M Sell
15,644
-63,110
-80% -$5.58M 0.23% 69
2018
Q2 		$6.25M Buy
78,754
+26,295
+50% +$2.18M 1.13% 36
2018
Q1 		$4.68M Buy
52,459
+32,334
+161% +$3.1M 0.85% 47
2017
Q4 		$2.1M Sell
20,125
-14,734
-42% -$1.66M 0.38% 72
2017
Q3 		$5.08M Buy
34,859
+4,713
+16% +$642K 0.94% 39
2017
Q2 		$3.92M Sell
30,146
-669
-2% -$82K 0.8% 55
2017
Q1 		$3.83M Buy
30,815
+30,805
+308,050% +$3.69M 0.77% 53
2016
Q4 		$1K Hold
10
– – ﹤0.01% 1015
2016
Q3 		$1K Hold
10
– – ﹤0.01% 1017
2016
Q2 		$1K Sell
10
-200
-95% -$20.7K ﹤0.01% 957
2016
Q1 		$21K Sell
210
-25
-11% -$2.57K ﹤0.01% 400
2015
Q4 		$28K Hold
235
– – 0.01% 336
2015
Q3 		$25K Hold
235
– – 0.01% 360
2015
Q2 		$27K Buy
235
+25
+12% +$2.86K 0.01% 366
2015
Q1 		$24K Sell
210
-90
-30% -$10.8K 0.01% 372
2014
Q4 		$34K Hold
300
– – 0.01% 322
2014
Q3 		$28K Hold
300
– – 0.01% 345
2014
Q2 		$26K Sell
300
-128
-30% -$9.73K 0.01% 360
2014
Q1 		$30K Sell
428
-44
-9% -$3.48K 0.01% 400
2013
Q4 		$40K Sell
472
-308
-39% -$24.4K 0.01% 327
2013
Q3 		$60K Buy
780
+292
+60% +$20.5K 0.02% 294
2013
Q2 		$29K Buy
+488
New +$29.4K 0.01% 429

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Howe & Rusling's CELG Position: Q4 2019 in Review

Howe & Rusling sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 325 shares — an estimated $32K sold.

Howe & Rusling first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $6.25M in Q2 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Howe & Rusling reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Howe & Rusling sold 325 Celgene Corp shares in Q4 2019, an estimated $32K.
  • Howe & Rusling first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Howe & Rusling's Celgene Corp position peaked at $6.25M in Q2 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Howe & Rusling's 13F filing for Q4 2019, filed 5 Feb 2020.